Article History
Received: 20 May 2021
Accepted: 27 July 2021
First Online: 10 August 2021
Declarations
:
: A.S. received lecture fees from Novo Nordisk Pharma Ltd., Tokyo, Japan, and Sanofi K.K., Tokyo, Japan. Other authors have no potential conflicts of interest relevant to this article.
: All procedures conducted herein were in accordance with the ethical standards of the institutional and national committees on human experimentation, as well as with the 1964 Helsinki Declaration and later versions.
: Written informed consent was obtained from the patient.